171 results on '"Lerche, Stefanie"'
Search Results
2. CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
3. Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
4. Association of elevated cerebrospinal fluid levels of the longevity protein α‐Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.
5. Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson’s Disease
6. Association of high alpha-Klotho-levels in CSF with a later onset of cognitive impairment in patients with Parkinson´s disease
7. Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies
8. Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD)
9. Effect of physical activity on cognitive flexibility, depression and RBD in healthy elderly
10. Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in elderly
11. Impact ofAPOEGenotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease
12. Reasons for mild parkinsonian signs – Which constellation may indicate neurodegeneration?
13. Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in elderly
14. Impact ofAPOEgenotype on cognition in idiopathic and genetic forms of Parkinson’s disease
15. Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
16. SNPs in Aβ clearance proteins: Lower CSF Aβ1-42 levels and earlier onset of dementia in PD
17. Cognitive impairment in Glucocerebrosidase (GBA)‐associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
18. Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson’s Disease Rating Scale in the elderly population
19. CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers
20. CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers
21. Risk factors and prodromal markers and the development of Parkinson’s disease
22. Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease.
23. CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB
24. Additional file 4 of Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson���s disease and dementia with Lewy bodies
25. Additional file 3 of Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson���s disease and dementia with Lewy bodies
26. Additional file 6 of Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson���s disease and dementia with Lewy bodies
27. Additional file 1 of Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson���s disease and dementia with Lewy bodies
28. Additional file 5 of Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson���s disease and dementia with Lewy bodies
29. The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease
30. The Mutation Matters: CSF Profiles of GCase , Sphingolipids, α‐Synuclein inPD GBA
31. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2
32. Enlarged hyperechogenic substantia nigra as a risk marker for Parkinsonʼs disease
33. CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
34. The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA.
35. The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA.
36. Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha‐Synuclein Profiles
37. Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha‐synuclein profile
38. REM sleep behaviour disorder (RBD): risk for Parkinsonism and executive dysfunction in elderly
39. Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease
40. Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles.
41. Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42 profiles in a prospective longitudinal study
42. Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease
43. Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs
44. Prodromal markers in Parkinson's disease: Limitations in longitudinal studies and lessons learned
45. Aiming for study comparability in Parkinson's disease: Proposal for a modular set of biomarker assessments to be used in longitudinal studies
46. Additional file 2: of Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs
47. Additional file 3: of Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs
48. Additional file 1: of Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs
49. Global, Yet Incomplete Overview of Cohort Studies in Parkinson’s disease
50. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.